Antidiabetic drug semaglutide molecular structure, illustration


Illustration of the molecular structure of semaglutide, a drug used to treat type-2 diabetes. Semaglutide is a GLP-1 agonist, meaning it mimics the function of natural GLP-1 hormones. GLP-1 hormones are released in the gastrointestinal tract when we eat. They work by binding to GLP-1 receptors throughout the body and stimulating insulin secretion, inhibiting glucagon secretion, and slowing down gastric emptying. These effects all lower blood sugar levels, making semaglutide a treatment option for type 2 diabetes. Atoms are represented as rods and are colour-coded: carbon (grey), nitrogen (blue) and oxygen (red).


Size: 4827px × 3620px
Location:
Photo credit: © RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, 2, 3, 3d, agonist, alpha, antidiabetic, artwork, background, biochemical, biochemistry, biological, biology, blood, cgi, control, diabetes, digitally, dimensional, drug, endocrine, endocrinological, endocrinology, generated, glp-1, glucagon-, glycaemic, glycemic, healthcare, helical, helix, hormone, illustration, loss, medical, medication, medicine, molecular, ozempic, peptide, peptide-1, pharma, pharmaceutical, pharmaceuticals, pharmacological, pharmacology, phospholipid, proteins, rods, rybelsus, semaglutide, structure, sugar, system, treatment, type, wegovy, weight, white